VERAVANTI INC.
Bothell, US · Founded 2013
Find your way into VERAVANTI INC.
Sign up to see every warm intro you have to VERAVANTI INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VERAVANTI INC. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VerAvanti develops ultra-small, single-use endoscopic imaging devices using patented scanning fiber technology for minimally invasive procedures. The company focuses on enabling clearer visualization and more efficient workflows for physicians during diagnostic and therapeutic interventions.
Founders & leadership
VERAVANTI INC. was founded in 2013 by Gerald McMorrow.


Board

Reported raises · per SEC filings
Form D private placements$28.9M disclosed across 2 rounds · 2017–2025
▶$28.3MraisedMar 2025 · 17 investors · OtherRule 506(b)
- Frederic MollDirector
- Michael MoyerDirector
- Eric SiebelExecutive Officer
- Juan VegarraExecutive Officer
- Luis SavastanoExecutive Officer
- David AuthDirector
- David GoeslingExecutive Officer
- Gerald McMorrowExecutive Officer, Director
- Offering amount
- $37.3M
- Amount sold
- $28.3M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$540KraisedMay 2017 · 5 investors · Other Health CareRule 506(b)
- Gerald McMorrowExecutive Officer, Director, Promoter
- Russell GarrisonExecutive Officer, Director
- David AuthDirector
- Offering amount
- $5M
- Amount sold
- $540K
- Minimum investment
- $60K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $286.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does VERAVANTI INC. do?
- VerAvanti develops ultra-small, single-use endoscopic imaging devices using patented scanning fiber technology for minimally invasive procedures. The company focuses on enabling clearer visualization and more efficient workflows for physicians during diagnostic and therapeutic interventions.
- Who founded VERAVANTI INC.?
- VERAVANTI INC. was founded by Gerald McMorrow in 2013.
- How much funding has VERAVANTI INC. raised?
- VERAVANTI INC. has disclosed $28.9M raised across 2 rounds.
- Where is VERAVANTI INC. headquartered?
- VERAVANTI INC. is headquartered in Bothell, US.